Canada markets closed

Khiron Life Sciences Corp. (KHRN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.3950+0.0150 (+3.95%)
At close: 3:59PM EST
Sign in to post a message.
  • T
    Thomi
    don't know from you guys who has linked in but Alvaro posted the following a few minutes ago;

    Yesterday Pirry, one of Colombia's top journalists and documentary makers, published this feed on his Instagram account @pirryoficial (1.5m followers!). In this feed he publicly acknowledges that he has become a medical cannabis patient. Pirry is a KHIRON patient and he is a ZERENIA patient for depression and insomnia. Every day, as these stories keep bringing the attention of the benefits of medical cannabis and KHIRON's leading role, we see more patients interested in getting new alternatives for their treatment. Soo happy to see people feeling better because of what we do in our clinics and with our products!!

    The link to Pirry's Instagram is;
    https://lnkd.in/eSJE-pk

    The guy talks in Spanish so again, don't know who of you speaks Spanish (but I do - and I covered for many years latin american market and was also living and working in Panama-City covering the LatAm region)
    20.6k Likes, 910 Comments - PirryOficial (@pirryoficial) on Instagram: “Pero medicinal. Y usted qué piensa? Es buena es mala? No sabe mucho al respecto?, le interesaría?.…”
    20.6k Likes, 910 Comments - PirryOficial (@pirryoficial) on Instagram: “Pero medicinal. Y usted qué piensa? Es buena es mala? No sabe mucho al respecto?, le interesaría?.…”
    scontent-dfw5-1.cdninstagram.com
  • J
    Jon
    Boom time.. Lets see what happens this year.. Bashers need not respond. Straight from Yahoo but they wont let me post their own link..lol

    Tue, January 12, 2021, 11:26 AM EST
    MEXICO CITY (Reuters) - Mexico's health ministry on Tuesday published rules to regulate the use of medicinal cannabis, a major step in a broader reform to create the world's largest legal cannabis market in the Latin American country.

    The new regulation was signed off by President Andres Manuel Lopez Obrador, and will now allow pharmaceutical companies to begin doing medical research on cannabis products.

    The cannabis reform taking place includes the recreational use of marijuana, and will create what would be the world's biggest national cannabis market in terms of population.

    Tue, January 12, 2021, 11:26 AM EST
    MEXICO CITY (Reuters) - Mexico's health ministry on Tuesday published rules to regulate the use of medicinal cannabis, a major step in a broader reform to create the world's largest legal cannabis market in the Latin American country.

    The new regulation was signed off by President Andres Manuel Lopez Obrador, and will now allow pharmaceutical companies to begin doing medical research on cannabis products.

    The cannabis reform taking place includes the recreational use of marijuana, and will create what would be the world's biggest national cannabis market in terms of population.

    - ADVERTISEMENT -

    The new medicinal rules state companies which wish to carry out research have to obtain permission from the Mexican health regulator, COFEPRIS, and this research has to be done in strictly controlled, independent laboratories.

    "The standard of regulation is very, very high," said Luisa Conesa, a lawyer and pro-cannabis activist who spearheaded legal challenges that led to decriminalization of medical cannabis.

    "(The regulation) is not aimed at patients growing their own cannabis, it is aimed at pharmaceutical companies producing pharmaceutical derivatives of cannabis which are classified as controlled substances that need prescription."

    The regulation also sets rules for the sowing, cultivation and harvesting of cannabis for medicinal purposes, which would allow businesses to grow marijuana legally on Mexican soil.

    While some cannabis plant imports are permitted for companies looking to create products, exports of Mexican-grown cannabis is prohibited.

    Foreign weed companies from Canada and the United States have been looking at Mexico with interest. Many had delayed making investment decisions due to policy uncertainty and were waiting for the final regulation to be published.

    Mexico's lawmakers are also in the final stages of legalizing recreational use of marijuana, with the bill expected to pass in the next period of Congress.

    The legislation marks a major shift in a country bedeviled for years by violence between feuding drug cartels, which have long made millions of dollars growing marijuana illegally and smuggling it into the United States.

    (Reporting by Drazen Jorgic; Additional reporting by Raul Cortes Fernandez; Editing by Dave Graham)
  • T
    ThaYoda
    Surprised this hasn’t shot through the roof. Khiron is holding the right cards in their hand.
  • U
    Ugo
    Hi, just took a huge profit with Canopy Rivers and I'm considering adding to my position in Khiron next week, but before I would like to figure out what happened with the acquisition of NettaGrowth and what are the expectations of the company concerning Uruguay. Does anybody (among serious investors) have a clue? Thanks.
  • j
    ju
    Biz only posts negative comments in any forum he’s in. A really delight to have around. Is the sky ever blue where you live ?
  • D
    Dan
    DECN. BIZ’s top pick is at 1 cent. Not 1 dollar. 1 cent. Down 25% today. Practically bankrupt. If anything you should be taking the opposite of his advice
  • S
    Sachin
    Download Investor Presentation today from here:

    https://investors.khiron.ca/investor-information
  • S
    Slim
    The investor presentation is updated on their website with 2021 goals ... looks pretty neat check it out!
  • a
    aasdfd
    Baggies, are you cash flow positive yet? Remember, Naprawa promised to break even by the end of 2020
  • J
    Jason
    quiet... too quiet...
  • J
    Jei Jei
    There will be ups and downs but 2021 growth will be important, with valuation around $2 per share by the end of the year. $4.5 by the end of 2022 and $7.5 per share by mid 2023.
  • R
    Robert
    Can anyone explain why this wouldn’t be a possible good play with Mexico going fully forward with Cannabis?
  • N
    NEHAL
    Going to buy 5K Monday morning...I already own few K @ 0.65 ..its time to add and average it...Company has a good management and soon Cannabis going to be legal in US, Once that happen we will see this stock over $3
  • k
    keenan
    wow, decided i would stop by this site as have owned khrnf since it was 3.00. mgmt has continued to basically say the same thing for 2.5 yrs yet this stock continues to be the dog goin lower week after week. Made really good money on renewable energy stocks so have held khrnf on a hope and a hail mary type attempt. This stock is big disapointment but will just hold because whats another .28 to lose per share after the losses already incurred on it. Def not buyin 1 more share as this stock could vanish at any point given its 2.5 yr downtrend. Good luck but is thinkin US legalization is gonna make a positive diff for this stock is quite a stretch isnt it? So much production waiting for introduction to US market I dont think khrin will benefit unless some big boy buys and we know how those deals work out for small fish company. Oh well, as i said fingers crossed.
  • J
    Jei Jei
    Nice volume. Nice growth. As I already mentioned, just the beginning of 2021 steady growth. Wait and see folks.
  • D
    Dan
    Check out another biz pic PLNHF. When I asked him for a winner he told me it was this stock! Down 8% today. Can’t imagine anyone would take your advice buddy
  • J
    John
    I hope our comeback is this year. I’ll be ecstatic if we reach $2-3
  • M
    Mark
    When are earnings due?
  • O
    Oxford
    In a country that does not allow cannabis dispensaries, our clinics offer a one-stop shop where patients can obtain a prescription, product recommendations, delivery service and follow up care. We believe clinic expansion will drive growth and that many of the strategies we’ve deployed have proven effective in other markets.

    Case in point, Trulieve Cannabis, which has a ~50% market share in the Florida market, is focused on physician education and outreach, superior customer service, patient loyalty and retention, brand development, multi-channel distribution, patient loyalty programs, and technological innovation. Its next leg of growth is expected to come from entries into new markets; as Trulieve has executed on this strategy, sales have increased from US$161,000 in Q4/16 to US$136 million in Q3/20!
  • D
    Dan
    Judging by the insider buying last month get ready for some good news real soon. Loading up shares as we speak...